UBS analyst John Lovallo raised the firm’s price target on D.R. Horton (DHI) to $193 from $191 and keeps a Buy rating on the shares. The stock warrants a higher valuation multiple given the firm’s view that FY26 will be a better year for housing and that opportunities exist for multiple expansion across the group as the market becomes more comfortable that a bottom in demand, consumer confidence and margins is approaching, the analyst tells investors in a research note.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DHI:
- Morning Movers: Fastenal and 3M slip following quarterly results
- D.R. Horton backs FY26 revenue view $33.5B-$35B, consensus $34.26B
- D.R. Horton sees Q2 revenue $7.3B-$7.8B, consensus $7.77B
- DHI Earnings: DR Horton Stock Jumps as Higher Home Sales Deliver Q1 Beat
- D.R. Horton up 2% at $159.23 after Q1 earnings beat